A detailed history of Fmr LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,539,913 shares of BBIO stock, worth $41.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,539,913
Previous 2,325,612 33.78%
Holding current value
$41.7 Million
Previous $71.9 Million 45.76%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$23.0 - $31.04 $18.1 Million - $24.4 Million
-785,699 Reduced 33.78%
1,539,913 $39 Million
Q1 2024

May 13, 2024

SELL
$27.35 - $40.45 $2.43 Million - $3.59 Million
-88,729 Reduced 3.68%
2,325,612 $71.9 Million
Q4 2023

Feb 13, 2024

SELL
$24.02 - $43.89 $316,607 - $578,514
-13,181 Reduced 0.54%
2,414,341 $97.5 Million
Q3 2023

Nov 13, 2023

BUY
$16.89 - $35.01 $12.9 Million - $26.8 Million
766,639 Added 46.16%
2,427,522 $64 Million
Q2 2023

Aug 11, 2023

SELL
$13.29 - $18.01 $5.89 Million - $7.98 Million
-443,351 Reduced 21.07%
1,660,883 $28.6 Million
Q1 2023

May 11, 2023

BUY
$7.17 - $18.55 $10 Million - $26 Million
1,401,129 Added 199.28%
2,104,234 $34.9 Million
Q4 2022

Feb 13, 2023

SELL
$6.74 - $11.52 $1.89 Million - $3.23 Million
-280,244 Reduced 28.5%
703,105 $5.36 Million
Q3 2022

Nov 10, 2022

BUY
$7.94 - $12.36 $23,716 - $36,919
2,987 Added 0.3%
983,349 $9.77 Million
Q2 2022

Aug 12, 2022

BUY
$5.21 - $12.14 $16,489 - $38,423
3,165 Added 0.32%
980,362 $8.9 Million
Q1 2022

May 13, 2022

SELL
$7.34 - $17.16 $1.5 Million - $3.52 Million
-204,839 Reduced 17.33%
977,197 $9.92 Million
Q4 2021

Feb 14, 2022

SELL
$11.38 - $53.41 $5.76 Million - $27 Million
-506,114 Reduced 29.98%
1,182,036 $19.7 Million
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $14.1 Million - $19.4 Million
301,462 Added 21.74%
1,688,150 $79.1 Million
Q2 2021

Aug 13, 2021

BUY
$46.47 - $63.93 $64.4 Million - $88.7 Million
1,386,688 New
1,386,688 $84.5 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.02B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.